LAB
Standard Biotools Inc
0.7399$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -348.6% | -299.1% | -187.1% | -76.8% | -34.3% | -40.9% | -33.4% | -2.2% | -19.4% | -30.2% | -37.4% | -23.6% | -22.3% | -30.0% | -11.2% | -33.7% | -91.2% | -40.7% | -82.2% | -87.1% | |
| 22.8% | 29.4% | 12.8% | 7.6% | 4.5% | 2.5% | 2.8% | 3.6% | 3.5% | 14.0% | 17.2% | 18.3% | 14.7% | 15.1% | 11.5% | 12.4% | 15.3% | 14.3% | 9.7% | 2.0% | |
| 2.3% | 9.7% | 13.2% | 8.3% | 4.7% | 6.5% | 7.8% | 9.0% | 18.0% | 14.7% | 13.3% | 8.9% | 9.8% | 9.7% | 10.5% | 12.3% | 15.2% | 12.3% | 18.2% | 34.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | 11.0% | 21.7% | 12.1% | 14.1% | 31.3% | – | – | – | |
| -18.8% | 7.0% | -16.0% | -10.5% | 5.6% | -2.3% | -7.8% | 9.4% | -6.7% | -7.2% | 4.5% | 9.0% | -2.2% | -14.1% | 1.7% | -13.8% | -12.6% | 1.7% | -6.9% | -52.7% | |
| 45.8% | 13.4% | 5.9% | 3.1% | 4.6% | 3.9% | 4.6% | 6.6% | 6.4% | 9.3% | 4.8% | 1.6% | 0.3% | 2.2% | 9.2% | 10.2% | 3.9% | 2.7% | 4.8% | 9.7% | |
| -46.0% | -92.6% | 39.1% | -2.7% | -4.0% | -105.2% | 26.8% | -38.7% | -153.2% | 22.4% | 43.2% | 17.3% | 4.2% | -33.5% | 28.9% | -9.1% | -90.0% | 19.0% | 208.2% | 29.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 1.3% | – | 0.2% | – | – | – | – | |
| -1.1% | – | – | – | – | – | – | – | – | -0.1% | -0.1% | 28.6% | 53.9% | -0.5% | -0.3% | -1.4% | -0.8% | -5.1% | -23.5% | 1.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | 2.8% | 2.7% | 11.8% | 12.5% | 5.7% | -2.0% | -36.2% | 0.0% | |
| 486.5% | 516.2% | 41.2% | 66.7% | 11.3% | 164.2% | 92.7% | 8.2% | 172.0% | 4.6% | 0.1% | 28.4% | 51.0% | 2.4% | 15.1% | 12.2% | 235.6% | -6.4% | -58.8% | 0.7% | |
| 91.5% | 124.5% | -106.1% | -12.6% | -26.5% | 18.3% | 86.2% | -32.9% | -1.3% | -4.0% | 5.7% | 22.6% | 33.1% | -61.1% | 33.2% | -30.7% | 54.0% | -28.0% | 66.7% | -56.5% | |
| -394.5% | -312.5% | -193.1% | -79.9% | -38.9% | -44.8% | -38.0% | -8.8% | -25.8% | -39.5% | -42.3% | -25.2% | -22.6% | -32.2% | -20.4% | -43.9% | -95.1% | -43.4% | -87.0% | -96.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.